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A B S T R A C T   
Malaria remains a heavy global burden on human health, and it is important to understand the molecular and 
cellular biology of the parasite to find targets for drug and vaccine development. The mouse malaria model is an 
essential tool to characterize the function of identified molecules; however, robust technologies for targeted gene 
deletions are still poorly developed for the widely used rodent malaria parasite, Plasmodium yoelii. To overcome 
this problem, we established a DiCre-loxP inducible knockout (iKO) system in P. yoelii, which showed more than 
80% excision efficacy of the target locus and more than 90% reduction of locus transcripts 24 h (one cell cycle) 
after RAP administration. Using this developed system, cAMP-dependent protein kinase (PKAc) was inducibly 
disrupted and the phenotypes of the resulting PKAc-iKO parasites were analyzed. We found that PKAc-iKO 
parasites showed severe growth and erythrocyte invasion defects. We also found that disruption of PKAc 
impaired the secretion of AMA1 in P. yoelii, in contrast to a report showing no role of PKAc in AMA1 secretion in 
P. falciparum. This discrepancy may be related to the difference in the timing of AMA1 distribution to the 
merozoite surface, which occurs just after egress for P. falciparum, but after several minutes for P. yoelii. Se-
cretions of PyEBL, Py235, and RON2 were not affected by the disruption of PKAc in P. yoelii. PyRON2 was 
already secreted to the merozoite surface immediately after merozoite egress, which is inconsistent with the 
current model that RON2 is injected into the erythrocyte cytosol. Further investigations are required to under-
stand the role of RON2 exposed on the merozoite surface.   
1. Introduction 
Malaria is still a major public health concern in the world [1]. The 
causative pathogens of malaria are obligate intracellular protozoan 
parasites which belong to the genus Plasmodium and are transmitted by 
Anopheles mosquitoes. In humans, parasites proliferate in erythrocytes 
and the clinical symptoms are caused by these blood stage parasites. 
Because malaria parasites are obligate intracellular organisms, eryth-
rocyte invasion is a critical step for their survival. Invasion is mediated 
by the sequential secretion of molecules from parasite organelles, 
including micronemes and rhoptries, which have unique roles such as 
interaction with erythrocyte receptors [2–4]. Secretion of these mole-
cules is regulated by intracellular calcium mobilization and phosphor-
ylation [5,6]. In Plasmodium falciparum, merozoite released from 
erythrocytes exposes them to the low potassium environment of the 
blood and triggers elevation of cytosolic calcium, which in turn stimu-
lates AMA1 and EBA-175 secretion from micronemes. Recognition of 
erythrocyte surface glycophorin A by EBA-175 restores basal cytosolic 
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calcium levels and triggers secretion of rhoptry body protein Clag3.1 
[2]. Signaling of AMA1 secretion is regulated by hierarchical phos-
phorylation by cyclic AMP (cAMP)-dependent protein kinase (PKA) and 
glycogen synthase kinase 3 (GSK3) [7,8]. cAMP is synthesized from ATP 
by adenylyl cyclase and works as a second messenger. Once the cellular 
cAMP concentration reaches a threshold level, PKA is activated and 
phosphorylates Ser610 of P. falciparum AMA1, which is essential for 
erythrocyte invasion [7,9–11]. This model was developed by analyzing 
P. falciparum, which can invade erythrocytes immediately after egress; 
however, other malaria parasite species such as P. yoelii and P. knowlesi 
require several minutes after egress for merozoites to achieve compe-
tency to invade erythrocytes, indicating that these parasites need to be 
activated after egress [12]. Understanding this activation process would 
provide insights to understand the erythrocyte invasion mechanisms of 
malaria parasites. 
To utilize reverse genetics to describe the function of essential 
parasite proteins for erythrocyte invasion, technologies are required to 
inducibly knock down or knock out target molecules. To this end, we 
have recently established a tetracycline-repressive transactivator (Tet- 
off) system in P. yoelii, but this system requires a time-consuming opti-
mization process to modify the 5′ untranslated region of the target gene 
[13]. In the present study we established a dimerisable Cre-recombinase 
(DiCre)-loxP inducible gene knockout system in P. yoelii by adapting 
methods developed for P. falciparum and P. berghei [14,15], and assessed 
the consequence of the disruption of PKAc in the erythrocyte invasion 
process of P. yoelii. 
2. Materials and methods 
2.1. Parasites and animal experiment 
The P. yoelii 17XL strain was maintained in 6–8 week old female ICR 
or BALB/c mice (Japan SLC, Hamamatsu, Japan). Animal experiments 
were approved by the Animal Care and Use Committee of Nagasaki 
University (Permit number: 1403031120–5). 
2.2. Plasmid construction and transfection 
The plasmid pBS_DC_hsp86/Bip5’ was a kind gift from M. Blackman 
[14]. The promoter to drive FRB-Cre60 and FKBP-Cre59 was replaced 
with the P. yoelii elongation factor 1 alpha (ef-1α) bi-directional pro-
moter (pBS-DC-Pyef-1α). The DiCre expression cassette was PCR- 
amplified from pBS-DC-Pyef-1α using oligonucleotide primers DiCre.F 
and DiCre.R, and ligated into the pDC2-cam-Cas9-PyU6-hDHFR plasmid 
using an In-Fusion HD cloning kit (Takara Bio Inc., Shiga, Japan), 
yielding pDC2-Cas9-DC-Pyef-1α [16]. A guide RNA (gRNA) sequence to 
introduce a double strand break in the p230p locus (PY17X_0306600) 
was designed using EupaGDT and ligated using T4 ligase (New England 
Biolabs, Ipswich, MA, USA). The 5′- and 3′- homologous regions (HRs) 
were PCR-amplified from parasite gDNA with oligonucleotide primers 
Pyp230p 5HR.F, Pyp230p-5HR.R, Pyp230p-3HR.F, and Pyp230p-3HR. 
R; and inserted into pDC2-Cas9-DC-Pyef-1α, yielding pDC2-Cas9- 
p230p-DC-Pyef-1α. 
The PKAc 5′- and 3’-HRs were PCR-amplified from parasite gDNA. A 
DNA fragment containing a loxP intron sequence [17] and recodonized 
PKAc cDNA sequence corresponding to exons 2 to 5 designed based on 
the codon usage of P. falciparum (3D7 strain) with the IDT codon opti-
mization tool (https://sg.idtdna.com/CodonOpt; GenScript Biotech, 
Piscataway, New Jersey, USA) were synthesized. Recodonization was 
done to avoid unwanted integration to this region in the genome by 
homologous recombination, instead of the 5’-HR. A DNA fragment 
containing hDHFR-yFCU open reading frame was PCR-amplified from 
pDC2-Cas9-PyU6-PypPK1-myc plasmid with primers PKAc-iKOhDHFR/ 
yFCU⋅F and PKAc-iKO-hDHFR/yFCU.R [16]. All PCR products were 
purified using a gel extraction kit and ligated into pDC2-Cas9-PyU6- 
hDHFR plasmid using an In-Fusion HD cloning kit, yielding pDC2- 
Cas9-PyU6-PKAc-iKO-hDHFR/yFCU. Transfection to P. yoelii was per-
formed as described [13]. Drinking water containing 1 mg/mL 5-fluoro-
cytosine (5-FC; Sigma-Aldrich, St. Louis, Missouri, USA) was orally 
administrated to mice infected with DiCre-expressing P. yoelii parasites 
to obtain parasites without the drug cassette, followed by cloning of 
transgenic parasites by limiting dilution [18]. The presence of the DiCre 
expression cassette and the loxP insertion sequences in the obtained 
parasites were verified by PCR-based genotyping using specific primer 
pairs (Table S1). 
2.3. Southern blotting 
Ten micrograms of gDNA extracted from DiCre-expressing parasites 
was double-digested with StuI and EcoRI, or SacI and KpnI. Genomic 
DNA from PKAc-iKO parasites was double-digested with EcoRV and AleI, 
or EcoRV and NotI. Digested gDNA was separated by agarose gel elec-
trophoresis, then transferred onto a HyBond N+ membrane (GE 
Healthcare, Buckinghamshire, U.K.). Four probes were generated: probe 
1 with primers (p230p-Probe1.F and p230p-Probe1.R) for the p230p 
sequence, probe 2 (Cre60-Probe2.F and Cre60-Probe2.R) for the cre60 
sequence, probe 3 (PKAc-Probe3.F and PKAc-Probe3.R) for the -pkac 
sequence, and probe 4 (hDHFR-Probe4.F and hDHFR-Probe4.R) for the 
hdhfr sequence. All probes were labeled and hybridized using an 
AlkPhos Direct kit (GE Healthcare) [19]. Chemiluminescent signal was 
developed with the CDP-star detection reagent (GE Healthcare) and 
detected with a multipurpose charge-coupled-device (CCD) camera 
system (Las-4000 mini EPUV; Fujifilm, Japan). 
2.4. Rapamycin treatment and evaluation of DiCre-loxP recombination 
efficacy 
Rapamycin (RAP; Sigma-Aldrich) was dissolved in DMSO (4 mg/mL) 
and stored at − 20 ◦C until use [15]. Schizont stage parasites were 
enriched using Nycodenz (1.077 g/mL; company info) and incubated at 
15 ◦C for 3 h until their maturation. Matured schizonts were intrave-
nously inoculated into mice and 4 mg/kg RAP resuspended in PBS was 
intraperitoneally administrated. Blood was collected from 3 mice at 3, 6, 
12, and 24 h after RAP administration. Parasite DNA was extracted using 
a QIAamp DNA blood mini kit (Qiagen, Hilden, Germany) and PCR and 
quantitative PCR (qPCR) were carried out to evaluate Cre-loxP recom-
bination efficacy. Excision efficacy was estimated by values obtained by 
two independent qPCR amplifications with primers P7 and P8 for 
uncleaved events and primers P9 and P10 for cleaved events. Excision 
efficacies (%) were calculated by the following formula: 100 x (values 
with P9/P10 primer set) / (values with P7/P8 primer set) + (values with 
P9/P10 primer set). 
2.5. RNA extraction, cDNA synthesis, and quantitative reverse- 
transcription polymerase chain reaction (qRT-PCR) 
To examine mRNA reduction levels of the DiCre-loxP system, infec-
ted blood of PKAc-iKO parasites was collected from 3 mice at 3, 6, 12, 
and 24 h after RAP or DMSO administration. Parasite pellets were 
resuspended in TRIzol (Thermo Fisher Scientific, Waltham, MA, USA) 
and total RNA was extracted according to the manufacturer's in-
structions. Extracted RNA was treated with DNase I (Promega, Madison, 
WI, USA) and further purified using an SV Total RNA Isolation System 
(Promega) kit. Complementary DNA (cDNA) synthesis was carried out 
using SuperScript III (Invitrogen, Carlsbad, CA, USA) following the 
manufacturer's instructions. qRT-PCR was performed to quantitate 
transcripts of recodonized pkac and met-trna synthetase with Power 
SYBR™ Green PCR Master Mix (Thermo Fisher Scientific) and specific 
primer pairs (Table S1) using a 7500 Real-Time PCR system (Applied 
Biosystems, Foster City, CA, USA). Values for pkac transcripts were 
normalized to those for met-trna synthetase transcripts. 
T. Ishizaki et al.                                                                                                                                                                                                                                 
Parasitology International 85 (2021) 102435
3
2.6. Western blotting 
Western blot analysis was performed to evaluate the DiCre protein 
expression level and the efficacy of Cre excision of the loxP pair. 
Parasite-infected erythrocytes were collected at 24 and 48 h after RAP 
administration, treated with 0.1% saponin, and proteins were extracted 
with 1% Triton X-100 in PBS containing protease inhibitor cocktail 
(cOmplete™; Sigma-Aidrich). SDS-PAGE and Western blot were per-
formed as described [16]. Membranes were probed for 1 h at room 
temperature (RT) with mouse anti-Cre monoclonal antibody (1:1000; 
2D8; Sigma-Aldrich), rabbit anti-FKBP12 antibody (1:1000; ab2918; 
Abcam, Cambridge, UK), mouse anti-Myc monoclonal antibody (1:1000; 
9B11; Cell Signaling Technology, Danvers, MA, USA), or rabbit anti- 
PyAMA1 polyclonal antibody (1:300) [20]. Secondary hybridization 
was with HRP-conjugated anti-mouse IgG or anti-rabbit IgG (1:12000; 
Promega) for 1 h at RT. Bands were detected as described [16]. The band 
intensities were quantified with ImageJ software [21]. 
2.7. Indirect immunofluorescent assay (IFA) 
IFA analysis was performed to evaluate the expression of FRB-Cre60 
and FKBP-Cre59 and the loss or the reduction of PKAc proteins. Thin 
blood smears on glass slides were prepared from infected mice at the 
same time points as samples collected for Western blot analysis. Smears 
were fixed with 4% paraformaldehyde and 0.075% glutaraldehyde 
(PFA-GTA) in PBS for 15 min at RT, permeabilized with 0.1% Triton X- 
100 in PBS for 10 min at RT, and further incubated in 3% BSA in PBS for 
1 h at RT for blocking. Mouse anti-Cre monoclonal antibody (1:250), 
rabbit anti-FKBP12 polyclonal antibody (1:250), or mouse anti-Myc 
monoclonal antibody (1:500) were used as primary antibodies. Alexa 
fluor 488-conjugated goat anti-mouse IgG or Alexa fluor 594-conjugated 
goat anti-rabbit IgG were used as secondary antibodies (1:1000). Smears 
were incubated with primary antibody for 1 h at RT and incubated with 
secondary antibody and 4′,6-diamidino-2-phenylindole (DAPI) for 30 
min at RT. IFA smears were mounted with antifade medium (VECTA-
SHIELD; Vector laboratories, Burlingame, CA, USA) and images were 
acquired using a confocal microscope (A1R; Nikon, Tokyo, Japan) with a 
60× N.A. 1.40 CFI Plan Apo VC oil-immersion objective lens (Nikon). 
2.8. Monitoring parasitemia 
PKAc-iKO parasites (106) were inoculated into three mice and RAP or 
DMSO was injected intraperitoneally when the parasitemias reached 
1%. Thin blood smears were prepared every 6 h from 24 to 48 h after 
inoculation and stained with Giemsa solution. To evaluate parasitemia, 
at least 5000 erythrocytes or 500 parasite-infected erythrocytes were 
counted. Parasite stages were classified into ring, small late trophozoite, 
large late trophozoite, and schizont stages. Small versus large late tro-
phozoites were distinguished based upon diameter; specifically, less 
than 50% of erythrocyte diameter versus equal to or more than 50%, 
respectively. Schizonts were defined as parasites with more than one 
nucleus. Statistical analysis was conducted using two-way ANOVA 
analysis and Tukey's multiple comparison test using GraphPad Prism 8 
(GraphPad software Inc., San Diego, CA). 
2.9. Invasion assay 
To evaluate invasion efficacy, an in vitro invasion assay was per-
formed as described [22]. Briefly, purified matured schizonts (108) were 
filtrated and released merozoites were mixed with erythrocytes and 
incubated for 18 h with a 5% O2, 5% CO2, and 90% N2 gas mixture. 
Giemsa-stained thin blood smears were prepared, and 10,000 erythro-
cytes were counted to estimate parasitemia. Significant difference of the 
parasitemia was evaluated by one-way ANOVA followed by Dunnett 
multiple comparison test using GraphPad Prism 8. 
2.10. Secretion assay 
To evaluate protein secretion from organelles to the merozoite sur-
face, a secretion assay was performed basically as described [16]. In 
brief, merozoites were filtrated at 15 ◦C and incubated for 0 or 10 min at 
37 ◦C, then were fixed with PFA-GTA for 15 min and transferred onto 
poly-L-lysine-coated cover slips. Cover slips were incubated with 3% BSA 
in PBS for 1 h, then with primary antibodies for 1 h. Primary antibodies 
were washed away with PBS, and then the coverslips were incubated 
with secondary antibodies for 30 min. Primary antibodies were rabbit 
anti-PyAMA1 (1:250) [20], mouse anti-Py235 (1:250; mAb 25.87, a 
kind gift from A. Holder) [23], rabbit anti-PyRON2 (1:250) antibody 
[20], rabbit anti-PyEBL antibody (1:250) [24], mouse anti-RON4 
monoclonal antibody (Ab48F8) (1:250; a kind gift from D. Narum) 
[25], mouse anti-RON5 antibody (1:250) [20], and mouse anti-RhopH2 
monoclonal antibody (mAb#25) (1:250) [26]]. Chicken anti-MSP1 
(1:500) antibody [20] was used to identify parasites and, when appli-
cable, mouse anti-HSP70 antibody was used to verify that parasite 
membranes were intact. The Alexa fluor 488-conjugated goat anti- 
chicken IgY (1:1000), Alexa fluor 568-conjugated goat anti-mouse IgG 
(1:1000), and Alexa fluor 647-conjugated anti-rabbit IgG (1:1000) were 
used as secondary antibodies. IFA images were acquired using a confocal 
microscope (A1R; Nikon) using a 60× N.A. 1.27 CFI Plan Apo Lambda 
60× oil-immersion objective lens (Nikon) under identical conditions for 
all assays. The “sum intensity” (a value obtained by summing up in-
tensity values of all pixels) and “signal-positive area” were obtained 
using NIS-elements software (Nikon). IFA images were also captured by 
super-resolution structured illumination microscopy (SR-SIM; LSM780/ 
ERYRA PS1; Zeiss, Germany) using a 100× N.A. 1.46 alpha Plan- 
Apochromat oil-immersion objective (Zeiss), and EM-CCD camera 
iXon DU885 (Andor, UK). SR-SIM images were processed using ZEN 
software (Zeiss). 
2.11. Time lapse analysis 
Time-lapse analysis was conducted as described [13]. RAP or DMSO 
was administrated to mice infected with PKAc-iKO parasites and 24 h 
later matured schizonts were enriched using Nycodenz as described 
above. Merozoites were obtained from matured schizonts by filtration 
and kept at 15 ◦C. Mouse erythrocytes were applied to μ-slide VI 0.4 
chambers (ibidi, Germany) and then purified merozoites were trans-
ferred into the slide chamber. Video images were captured at 2 fps for up 
to 40 min using a CCD camera (ORCA-R2; Hamamatsu Photonics, 
Japan) at 37 ◦C under a temperature controller system (Tokai Hit, 
Japan). Obtained video images were converted to AVI format using NIS- 
Element software (Nikon). A merozoite was judged as “non-detachment” 
if it did not invade and did not detach from an erythrocyte greater than 
or equal to 300 s after an erythrocyte deformation event. The frequency 
of each invasion event was statistically analyzed with Fisher's exact test 
using GraphPad Prism 8. 
3. Results 
3.1. Generation of a P. yoelii line constitutively expressing DiCre 
To generate DiCre-expressing P. yoelii, a DNA fragment containing a 
DiCre expression cassette and a hDHFR-yFCU expression cassette was 
integrated into the Pyp230p gene locus, which is dispensable in all 
development stages [27] (Fig. 1A). After validating the insertion of this 
DNA fragment into the target genome locus by genotype PCR, parasites 
were treated with 5-FC to remove the hDHFR-yFCU expression cassette, 
then cloned by limiting dilution. Modification of the target gene locus 
was verified by genotype PCR and Southern blot analysis for all cloned 
parasite lines (Fig. 1B and C). Western blot analysis with an anti-Cre 
antibody that recognizes FRB-fused Cre60 (FRB-Cre60) or anti-FKBP12 
antibody that recognizes FKBP12-fused Cre59 (FKBP-Cre59) revealed 
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single bands at around 45 kDa or 19 kDa, respectively, consistent with 
the estimated molecular weight of these proteins (Fig. 1D). Protein ex-
tracts from wild type parasites did not show these bands, excluding 
potential non-specific reactions of anti-Cre or anti-FKBP12 antibodies. 
Western blot analysis with anti-AMA1 antibody ensured that the loaded 
protein amounts were similar (Fig. 1D bottom). IFA confirmed expres-
sion of FRB-Cre60 and FKBP-Cre59 at both the ring and schizont stages 
of DiCre-expressing P. yoelii clones, which largely colocalized with the 
nucleus signal (Fig. 1E). qRT-PCR revealed that the amount of cre60 
transcripts normalized by those of met-trna synthetase was not reduced 
for 29 days (9 passages in mice), indicating stable cre60 transcription in 
the generated clone for at least one month (Fig. S1). Thus, we success-
fully generated P. yoelii clones constitutively expressing FRB-Cre60 and 
FKBP-Cre59 from their genome. 
3.2. Generation of P. yoelii lines in which the PKAc gene locus can be 
inducibly disrupted 
To further validate the developed DiCre system, we generated 
P. yoelii PKAc-iKO clones in which the PKAc gene locus can be inducibly 
disrupted by RAP administration (Fig. 2A). Modification and induced 
deletion of the PKAc gene locus was confirmed by PCR and Southern blot 
analysis (Fig. 2B and C). A clear positive 4.1 kb band was amplified by 
PCR with primers specific for the excised PKAc gene locus 24 h after RAP 
administration, but a faint 4.1 kb band was also observed before the 
addition of RAP in PKAc-iKO parasites, suggesting excision due to leaky 
expression of DiCre proteins without RAP. To examine the efficacy and 
timing of excision of the target region and the occurrence of undesired 
excision without RAP, qPCR and qRT-PCR were performed for samples 
collected at 0, 3, 6, 12, and 24 h after RAP or DMSO administration. The 
excision efficacy in PKAc-iKO clones #1 and #2 were 38 ± 2% and 36 ±
3% at 3 h after RAP administration, respectively, which reached 86 ±
3% and 85 ± 3% at 24 h after RAP administration, respectively. 
Meanwhile, excision was observed in PKAc-iKO clones #1 and #2 with 
DMSO at 24 h at rates of 10 ± 5% and 11 ± 1%, respectively (Fig. 2D). 
The estimated amount of pkac transcripts in PKAc-iKO #1 and #2 were 
reduced to 8 ± 0.0% and 3 ± 0.2% at 24 h after RAP administration, 
respectively (Fig. 2E). In addition, Western blot analysis of PKAc-iKO 
clones with anti-Myc antibody revealed a band around 43 kDa, consis-
tent with the expected molecular weight of the PKAc protein, 43.8 kDa, 
before RAP administration (Fig. 2F NI). Normalized band intensities of 
samples with RAP treatment were much lower than those with DMSO 
Fig. 1. Generation of DiCre-expressing parasites. 
(A) Schematic of plasmid pDC2-Cas9-PyU6-p230p_DiCre, to generate DiCre expressing parasites. The DiCre expression cassette was designed to be integrated into the 
P. yoelii p230p (PY17X_0306600) gene locus. FRB-fused Cre60 (FRB-Cre60) and FKBP12-fused Cre59 (FKBP-Cre59) were driven by the bi-directional P. yoelii EF-1α 
promoter. (B) Genotyping PCR to evaluate the modification of the p230p gene locus. Expected band sizes are 3.2 kb in the parental wild type (WT) and 7.3 kb in DiCre 
(#1 and #2) parasites with primers P1 and P2 (P1xP2), no band in WT and 2.7 kb in DiCre parasites with primers P1 and P3 (P1xP3), and no band in WT and 3.4 kb 
in DiCre parasites with primers P2 and P4 (P2xP4). (C) Southern blot analysis to confirm the integration of the DiCre expression cassette. Probe 1 detected a 3.9-kb 
band in WT and a 2.8-kb band in cloned DiCre (#1 and #2) parasites. Probe 2 detected a 2.6-kb band in cloned DiCre parasites. The pDC2-Cas9-PyU6-p230p_DiCre 
plasmid digested with KpnI was used as a control with an expected size of 13 kb. (D) Western blot analysis to confirm FRB-Cre60 and FKBP-Cre59 expression. Purified 
schizont proteins were extracted with Triton X-100 and reacted with anti-Cre, anti-FKBP12, or anti-PyAMA1 antibodies. Bands were detected around 45.1 kDa and 
19.1 kDa for FRB-Cre60 and FKBP-Cre59, respectively. PyAMA1 was used as a loading control. (E) Dual IFA of ring and schizont stage DiCre parasites for FRB-Cre60 
and FKBP-Cre59. Fluorescent signals with anti-Cre antibody (green), anti-FKBP12 (red), and DAPI nucleus signals (blue) were merged with differential interference 
contrast (DIC) images. Scale bar: 5 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
T. Ishizaki et al.                                                                                                                                                                                                                                 
Parasitology International 85 (2021) 102435
5
Fig. 2. Evaluation of DiCre-loxP recombination efficacy. 
(A) Schematic of the plasmid to generate PKAc-iKO parasites (pDC2-Cas9-PyU6-PKAc-iKO-hDHFR/yFCU). An artificial loxP-intron was inserted between PKAc exon 1 
and 2 in DiCre-expressing parasites. The sequence of exon 2 to exon 5 encoding PKAc was recodonized. Another loxP sequence was inserted between the hDHFR- 
yFCU expression cassette and the 3′ homology arm (HR2). (B) Genotyping PCR to evaluate the insertion and the excision of the DNA fragment in the PKAc gene locus. 
The expected PCR band size is 5.6 kb in WT and 8.2 kb in transgenic parasites after the insertion of CRISPR editing. The expected band size after the excision of the 
floxed region by RAP treatment is 4.1 kb. The gDNA was extracted from parasites 24 h after RAP or DMSO administration. (C) Southern blot analysis to confirm the 
modification of the PyPKAc gene locus. Probe 3 detected a 4.2 kb band in the parental DiCre parasite (#1) and a 7.2 kb band in the cloned PKAc-iKO parasites (#1 
and #2). Probe 4 detected a 4.5 kb band in cloned PKAc-iKO parasites. pDC2-Cas9-PyU6-PKAc-iKO-hDHFR/yFCU plasmid digested with EcoRV was used as a control 
and the expected band size was 9.4 kb. (D) Ratio of intact PKAc gene locus. The proportion of the intact PKAc gene locus was estimated by qPCR at 0, 3, 6, 12, and 24 
h after RAP or DMSO administration. (E) Relative amounts of PKAc transcripts were estimated by qRT-PCR at 0, 3, 6, 12, and 24 h after RAP or DMSO administration. 
(F) Western blot analysis to evaluate the relative amount of PKAc protein after RAP administration. An approximately 43 kDa band was detected with anti-Myc 
antibody. AMA1 served as a loading control. (G) The band intensities of PKAc in panel F were normalized with those of AMA1. 
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treatment at 24 h (14% and 28% for clones #1 and #2, respectively) and 
48 h (15% and 12% for clones #1 and #2, respectively) after RAP 
administration (Fig. 2F and G). 
3.3. PyPKAc is required to invade erythrocytes 
Because the PKAc gene locus has been inducibly knocked out in 
P. falciparum [11], we compared the reported phenotype with P. yoelii. 
Firstly, we found that the growth of PKAc-iKO parasites treated with 
RAP was significantly lower than those treated with DMSO (Fig. 3A), 
consistent with the observation in P. falciparum. The parasitemias of 
wild type 17XL and cloned DiCre parasites with RAP treatment were not 
significantly different among all groups, indicating that RAP treatment 
had no effect on parasite growth (Fig. S2). Secondly, parasite stages 
affected by the excision of the PKAc gene locus were evaluated by 
comparing the proportion of the four asexual intraerythrocytic stages: 
early trophozoite (ring), small and late trophozoite, and schizont. The 
proportion of the ring stage was significantly reduced in both PKAc-iKO 
clones at 24 to 48 h after RAP treatment (Fig. 3B and Fig. S3), suggesting 
that PKAc had a role in parasite egress from or invasion into erythro-
cytes. Erythrocyte invasion assays performed in vitro with purified 
merozoites of PKAc-iKO clones revealed that invaded parasites with RAP 
treatment (0.04% and 0.06% for #1 and #2, respectively) were signif-
icantly lower than those treated with DMSO (0.8% and 0.9% for #1 and 
#2, respectively) (Fig. 3C). These data indicate that PKAc plays a role 
during erythrocyte invasion by P. yoelii, again consistent with the 
observation in P. falciparum. 
3.4. AMA1 secretion was significantly reduced by disrupting PKAc in 
P. yoelii 
Because secretion of the parasite ligands from the micro-organelles is 
essential for successful erythrocyte invasion, we investigated the effect 
of the disruption of PKAc on the secretion of several invasion-related 
organelle molecules. Firstly, we examined a microneme protein 
AMA1, whose cytoplasmic region was reported to be phosphorylated by 
PKAc in P. falciparum [11,28]. We found that AMA1 was detectable on 
the apical end of the merozoites purified at 15 ◦C. In P. falciparum, 
secretion of AMA1 is proposed to be triggered by egress and AMA1 is 
immediately distributed to the entire merozoite [29]. Analysis of DMSO- 
treated merozoites showed that the AMA1 signal-positive area was 
significantly increased after 10 min incubation, indicating that P. yoelii 
AMA1 was distributed from the apical end to the entire surface during 
that time span (Fig. 4C). The P. yoelii merozoite changes its shape from 
elongated to spherical after egress from the infected erythrocyte and 
prior to invasion [12]. Super-resolution microscopy visualized that the 
spread of AMA1 on the merozoite surface coincided with this morpho-
logical change of the merozoite (Fig. S4). Just after purification and after 
10 min incubation at 37 ◦C, the sum intensity and the positive area of the 
merozoite surface AMA1 signal was significantly reduced by disrupting 
the PKAc gene locus with RAP treatment in comparison with the DMSO 
control (Fig. 4A-C). This result indicated that AMA1 secretion was 
impaired without PKAc in P. yoelii, in contrast to the report that AMA1 
secretion in P. falciparum was not affected by disrupting PKAc [11]. 
3.5. RON2 is secreted onto the entire merozoite surface before attachment 
to the erythrocyte 
We evaluated the effects of PKAc disruption on the secretion of 
another molecule, rhoptry neck protein 2 (RON2). RON2 is proposed to 
be injected into the invading erythrocyte and inserted into the eryth-
rocyte membrane from the erythrocyte cytosol, to then make a complex 
with AMA1 to form a moving junction which serves as a scaffold for 
merozoite invasion. We found that RON2 was readily detectable on the 
entire merozoite surface just after purification, a time at which mero-
zoites showed an elongated shape (Fig. 4D and S4). Following PKAc 
disruption, the sum intensity and signal-positive area of RON2 were not 
significantly different than in the presence of PKAc (Fig. 4E and F), 
indicating that RON2 secretion is independent of PKA and AMA1 
secretion. 
We examined additional P. yoelii invasion ligands EBL and Py235 (a 
homolog of P. falciparum reticulocyte binding protein like (RBL) pro-
teins). PyEBL was detectable on the merozoite surface after 10 min in-
cubation (Fig. 5A) as described [13] and Py235 was detected on the 
merozoite surface just after merozoite purification (Fig. 5D). Their 
secretion pattern did not change by PKAc disruption (Fig. 5B and C for 
PyEBL and 5E and 5F for Py235), indicating that secretion of EBL and 
Py235 are independent of PKAc and AMA1 secretion. We sought to 
examine the secretion of other rhoptry proteins, RON4, RON5, and 
RhopH2, but they were not detectable on the surface of the purified 
merozoite even after 10 min incubation at 37 ◦C (Fig. S5). 
Fig. 3. P. yoelii PKAc is involved in erythrocyte invasion. 
(A) Parasitemias were monitored at 0, 24, 30, 36, 42, and 48 h after RAP or DMSO administration for PKAc-iKO clones #1 and #2. Parasitemias of the RAP group 
significantly lower than that of the DMSO group are indicated with asterisks (*, p < 0.05; ***, p < 0.001; ****, p < 0.0001 by two-way ANOVA post-hoc Tukey's 
multiple comparison test). (B) The proportion of early trophozoite (ring), small late trophozoite, large late trophozoite, and schizont stages at 0, 24, 30, 36, 42, and 
48 h after RAP administration were evaluated for PKAc-iKO #1 parasites. (C) In vitro erythrocyte invasion assay. The invasion efficacy of PKAc-iKO #1 and #2 
parasites treated with RAP was significantly lower than those treated with DMSO (Tukey's multiple comparison test). 
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3.6. Merozoites without PKAc were not able to complete the invasion 
process and were arrested on the erythrocyte surface 
To determine the invasion steps inhibited by disrupting PKAc in 
P. yoelii, RAP- or DMSO-pretreated purified merozoites were mixed with 
fresh mouse erythrocytes and invasion events were recorded for 40 min 
for analysis as described [13]. We observed more than 60 merozoites 
attached to the erythrocyte for all experimental groups. Representative 
images and videos are provided (Fig. 6A selected from Video 1 and 
Video 2). The number of erythrocyte deformation events per number of 
merozoite attachment events in RAP-treated groups was 65% and 67% 
for clones #1 and #2, respectively, which were not significantly 
different from those in DMSO-treated groups (80% and 68% for clones 
#1 and #2 left panel) (Fig. 6B). This result indicated that disruption of 
PKAc did not affect merozoite initial attachment to the erythrocyte and 
the merozoite motor machinery, because erythrocyte deformation is 
thought to be caused by merozoite gliding motility [30]. The number of 
echinocytosis events per number of erythrocyte deformation events in 
RAP-treated groups were 0% and 2.1% for clones #1 and #2, respec-
tively, which were significantly lower than those in DMSO-treated 
groups (20% and 37% for clones #1 and #2, respectively) (p < 0.001; 
Fig. 6B middle panel), indicating that disruption of PKAc had a signifi-
cant negative impact on merozoite internalization into the erythrocyte. 
The number of merozoite detachment events from the erythrocyte per 
number of erythrocyte deformation events in RAP-treated groups was 
28% and 27% for clones #1 and #2, respectively, which were not 
significantly different from those in DMSO-treated groups (29% and 
26% for clones #1 and #2, respectively) (Fig. 6B right panel), indicating 
that even following PKAc disruption the tight junction between the 
invading merozoite and erythrocyte was formed. This phenotype is 
consistent with the observation in P. falciparum [11]. 
4. Discussion 
Functional genomics, including targeted gene disruption methodol-
ogies, is important to identify targets of drug and vaccine development. 
For Plasmodium, gene disruption is facilitated by the haploid genome of 
the parasite but hindered by the fact that most knockout methods 
require genetic manipulation of asexual stage parasites. Asexual stage 
parasites express 45% of all parasite-encoded molecules, and many are 
difficult to disrupt and characterize due to their essentiality in this stage. 
To overcome this problem, inducible molecular genetics approaches, for 
Fig. 4. PyPKAc regulates PyAMA1 secretion but not PyRON2 secretion. 
(A) AMA1 secretion assay for PKAc-iKO parasites with or without rapamycin (RAP). (B) Sum intensity and (C) signal-positive area of AMA1 in PKAc-iKO parasites. 
(D) RON2 secretion assay for PKAc-iKO parasites with or without RAP. (E) Sum intensity and (F) signal-positive area of RON2 in PKAc-iKO parasites. Merozoite 
surface protein 1 (MSP1, green), heat shock protein 70 (HSP70, yellow), and AMA1 or RON2 (red). All images were merged with DAPI nucleus signals. RAP 
administration status is indicated as with (+) or without (− ). Parasites were not treated with Triton X-100 unless indicated as (+). Scale bar is 2 μm. Sum intensity 
and signal-positive area (AMA1 or RON2 signal-positive area divided by MSP1 signal-positive area) were calculated with NIS-elements software. Differences were 
examined by pair-wise Mann-Whitney U test and p < 0.01 was taken as a significant difference. (For interpretation of the references to colour in this figure legend, the 
reader is referred to the web version of this article.) 
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instance transcriptional knockdown using the Tet on/off system, were 
developed in rodent malaria parasites [13,31]. However, the Tet on/off 
system approach requires a time-consuming optimization process for 
each modification. Thus, in the present study the DiCre-loxP inducible 
gene knockout system, which utilizes dimerization of FRB-Cre60 and 
FKBP-Cre59 with RAP for activation, was applied to P. yoelii based on 
the system developed in P. falciparum and P. berghei [14,15]. In our 
developed system in P. yoelii more than 80% excision efficacy of the 
target locus and more than 90% reduction of the transcripts 24 h (one 
cycle) after RAP administration were observed, consistent with the re-
ports for P. falciparum and P. berghei, which showed recombination ef-
ficacy with more than 80% in one cycle (48 or 24 h, respectively) 
[15,17]. Indeed, we were able to observe an apparent phenotype on 
protein secretion from PKAc-iKO merozoites with RAP administration, 
indicating the usefulness of the developed system in P. yoelii. 
We found that AMA1 secretion was impaired without PKAc in 
P. yoelii, in contrast to a report that P. falciparum was able to secret 
AMA1 normally following PKAc disruption [11]. One explanation is that 
phosphorylation of the AMA1 cytoplasmic region is required for the 
secretion of this molecule in P. yoelii, but not in P. falciparum. We re-
ported that P. yoelii cannot invade erythrocytes immediately after 
egress, whereas P. falciparum was readily invasive at this timepoint [12]; 
although the underlying molecular mechanism for this observation is 
unclear. In this study, we found that the timing of AMA1 distribution on 
the merozoite surface is different between P. yoelii and P. falciparum; 
specifically, in P. yoelii AMA1 was not distributed to the merozoite 
surface for several minutes after release from the erythrocyte, whereas it 
is detectable over a large surface area of matured P. falciparum mero-
zoites just after egress. It is of interest to explore if these differences in 
AMA1 behavior are related to the difference in the invasion phenotype 
between the two Plasmodium species. 
Following PKAc disruption in P. falciparum, Patel et al. (2019) found 
that shedding of P. falciparum AMA1 was impaired and raised the pos-
sibility that the loss of interaction of unphosphorylated AMA1 and RON2 
resulted in a failure of erythrocyte invasion [11]. This conclusion was 
based in part on a similar invasion inhibitory phenotype observed when 
the AMA1-RON2 interaction is inhibited by a peptide termed R1 
[32,33]. In this study we observed that when PKAc is knocked out, the 
P. yoelii parasite was not able to secret AMA1 efficiently and its inter-
action with RON2 is expected to be reduced - thus AMA1 is directly 
involved in the reduced invasion phenotype in P. yoelii. It is plausible 
that other mechanisms that require PKA-dependent phosphorylation are 
also impaired in P. yoelii and participate in the reduced erythrocyte in-
vasion activity, as proposed for P. falciparum [11]. 
Signal for RON2, but not RON4 and RON5, was detected on the 
merozoite surface just after purification in P. yoelii. The surface location 
of RON2 seems to be incompatible with the currently proposed role of 
RON2 in apicomplexan parasites; specifically, that a part of RON2 is 
exposed on the erythrocyte membrane, which is inserted from the 
erythrocyte cytosol, and interacts with AMA1 to form a moving junction 
[34–36]. RON2 located on the merozoite surface is unlikely to be 
injected into the erythrocyte cytosol. It is possible that a portion of 
Fig. 5. Disruption of PyPKAc did not alter the secretion pattern of PyEBL and Py235. 
(A) PyEBL secretion assay for PKAc-iKO parasites with or without rapamycin (RAP). (B) Sum intensity and (C) signal-positive area of PyEBL in PKAc-iKO parasites. 
(D) Py235 secretion assay for PKAc-iKO parasites with or without RAP. (E) Sum intensity and (F) signal-positive area of Py235 in PKAc-iKO parasites. EBL and Py235 
signals are shown as red and other information is as described in Fig. 4. Scale bar is 2 μm. (For interpretation of the references to colour in this figure legend, the 
reader is referred to the web version of this article.) 
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RON2 remains in the rhoptry neck and is injected into the erythrocyte 
cytosol to function as proposed. Any role of RON2 secreted to the 
merozoite surface just after the egress remains to be elucidated. 
In conclusion, we established a DiCre-loxP-based inducible knock 
out system in P. yoelii and applied the system to evaluate PyPKAc 
functions. We found that disruption of PKAc impaired parasite growth; 
inhibited erythrocyte invasion; and diminished the secretion of AMA1, 
in contrast to a report in P. falciparum showing no role of PKAc in AMA1 
secretion. We found that PyRON2 was secreted to the merozoite surface 
just after purification, which complicates the current model that RON2 
is injected into the erythrocyte cytosol. This finding needs further 
investigation to understand the role, if any, of RON2 exposed on the 
merozoite surface. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.parint.2021.102435. 
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